Aims The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B virus strains causing infection in the Indian population. Further, we wanted to analyze the biological significance of these mutations in HBV mediated disease. Methods 222 HBsAg positive patients were enrolled in the study. The genotype and mutation profile was determined for the infecting HBV isolate by sequencing overlapping fragments. These sequences were analyzed by using different tools and compared with previously available HBV sequence information. Mutation Frequency Index (MFI) for the Genes and Diagnosis group was also calculated. Results HBV Genotype D was found in 55% (n = 121) of the patient group and genotype A was found in 30% (n = 66) of samples. The majority (52%) of the HBV-infected individuals in the present study were HBeAg-negative in all the age groups studied. Spontaneous drug associated mutations implicated in resistance to antiviral therapy were also identified in about quarter of our patients, which is of therapeutic concern. The MFI approach used in the study indicated that Core peptide was the most conserved region in both genotypes and Surface peptide had highest mutation frequency. Few mutations in X gene (T36A and G50R) showed high frequency of association with HCC. A rare recombinant strain of HBV genotype A and D was also identified in the patient group. Conclusions HBV genotype D was found out to be most prevalent. More than half of the patients studied had HBeAg negative disease. Core region was found to be most conserved. Drug Associated mutations were detected in 22% of the patient group and T36A and G50R mutations in X gene were found to be associated with HCC.
References
[1]
Datta S (2008) An overview of molecular epidemiology of hepatitis B virus (HBV) in India. VirolJ 5: 156–156. doi: 10.1186/1743-422x-5-156
[2]
Lavanchy D (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34 (Suppl 1) S1–3. doi: 10.1016/s1386-6532(05)00384-7
[3]
Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, et al. (2001) Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34: 590–594. doi: 10.1053/jhep.2001.27221
[4]
Alam MM, Zaidi SZ, Malik SA, Shaukat S, Naeem A, et al. (2007) Molecular epidemiology of Hepatitis B virus genotypes in Pakistan. BMC InfectDis 7: 115–115. doi: 10.1186/1471-2334-7-115
[5]
Fujiwara K, Tanaka Y, Orito E, Ohno T, Kato T, et al. (2005) Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. World J Gastroenterol 11: 6410–6415.
[6]
Kurbanov F, Tanaka Y, Fujiwara K, Sugauchi F, Mbanya D, et al. (2005) A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J GenVirol 86: 2047–2056. doi: 10.1099/vir.0.80922-0
[7]
Zekri AR, Hafez MM, Mohamed NI, Hassan ZK, El-Sayed MH, et al. (2007) Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection. VirolJ 4: 74–74. doi: 10.1186/1743-422x-4-74
[8]
Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J GenVirol 83: 2059–2073.
[9]
Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, et al. (2007) Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J InfectDis 195: 5–11. doi: 10.1086/509894
[10]
Liu WC, Phiet PH, Chiang TY, Sun KT, Hung KH, et al. (2007) Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics. Virus Res 129: 212–223. doi: 10.1016/j.virusres.2007.07.016
[11]
Tong S, Kim KH, Chante C, Wands J, Li J (2005) Hepatitis B Virus e Antigen Variants. IntJ MedSci 2: 2–7.
[12]
Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, et al. (2008) Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 14: 1777–1780. doi: 10.3201/eid1411.080437
[13]
Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, et al. (2009) A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 83: 10538–10547. doi: 10.1128/jvi.00462-09
[14]
Tran TT, Trinh TN, Abe K (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82: 5657–5663. doi: 10.1128/jvi.02556-07
[15]
Kuang SY, Jackson PE, Wang JB, Lu PX, Munoz A, et al. (2004) Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A 101: 3575–3580. doi: 10.1073/pnas.0308232100
[16]
Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C (2006) Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 25: 3823–3833. doi: 10.1038/sj.onc.1209559
[17]
Madan K, Batra Y, Sreenivas V, Mizokami M, Tanaka Y, et al. (2009) HBV genotypes in India: do they influence disease severity? Hepatol Res 39: 157–163. doi: 10.1111/j.1872-034x.2008.00417.x
[18]
Acharya SK, Madan K, Dattagupta S, Panda SK (2006) Viral hepatitis in India. Natl Med J India 19: 203–217.
[19]
Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK (2002) Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J GastroenterolHepatol 17: 165–170. doi: 10.1046/j.1440-1746.2002.02605.x
[20]
Kumar A, Kumar SI, Pandey R, Naik S, Aggarwal R (2005) Hepatitis B virus genotype A is more often associated with severe liver disease in northern India than is genotype D. Indian J Gastroenterol 24: 19–22.
[21]
Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, et al. (2006) Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J MedVirol 78: 1164–1174. doi: 10.1002/jmv.20677
[22]
Borkakoty BJ, Mahanta J, Biswas D (2008) Circulating genotypes of hepatitis B virus in Arunachal Pradesh. Indian J Med Res 127: 65–70.
Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, et al. (1999) Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J ClinMicrobiol 37: 2899–2903.
[25]
Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK (2004) Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127: 1356–1371. doi: 10.1053/j.gastro.2004.08.003
[26]
de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, et al. (2005) An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21: 3797–3800. doi: 10.1093/bioinformatics/bti607
[27]
Alcantara LCJ, Cassol S, Libin P, Deforche K, Pybus OG, et al. (2009) A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res 37: 634–642. doi: 10.1093/nar/gkp455
[28]
Liu TF, Shafer RW (2006) Web resources for HIV type 1 genotypic-resistance test interpretation. ClinInfectDis 42: 1608–1618. doi: 10.1086/503914
[29]
Beerenwinkel N, Daumer M, Oette M, Korn K, Hoffmann D, et al. (2003) Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res 31: 3850–3855. doi: 10.1093/nar/gkg575
[30]
Ewing B, Green P (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8: 186–194. doi: 10.1101/gr.8.3.175
[31]
Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, et al. (2002) Cancer patterns in eastern India: the first report of the Kolkata cancer registry. IntJ Cancer 100: 86–91. doi: 10.1002/ijc.10446
[32]
Gandhe SS, Chadha MS, Arankalle VA (2003) Hepatitis B virus genotypes and serotypes in western India: lack of clinical significance. J MedVirol 69: 324–330. doi: 10.1002/jmv.10292
[33]
Chattopadhyay S, Das BC, Kar P (2006) Hepatitis B virus genotypes in chronic liver disease patients from New Delhi, India. World J Gastroenterol 12: 6702–6706.
[34]
Brunetto MR, Oliveri F, Colombatto P, Coco B, Ciccorossi P, et al. (2003) Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon. J Hepatol 39 (Suppl 1) S164–167. doi: 10.1016/s0168-8278(03)00329-5
[35]
Funk ML, Rosenberg DM, Lok AS (2002) World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 9: 52–61. doi: 10.1046/j.1365-2893.2002.00304.x
[36]
Karayiannis P, Alexopoulou A, Hadziyannis S, Thursz M, Watts R, et al. (1995) Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 22: 1628–1634. doi: 10.1002/hep.1840220603
[37]
Guo X, Jin Y, Qian G, Tu H (2008) Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 49: 718–725. doi: 10.1016/j.jhep.2008.06.026
[38]
Song BC, Cui XJ, Kim HU, Cho YK (2006) Sequential accumulation of the basal core promoter and the precore mutations in the progression of hepatitis B virus-related chronic liver disease. Intervirology 49: 266–273. doi: 10.1159/000093456
[39]
Mizokami M, Orito E (1999) Molecular evolution of hepatitis viruses. Intervirology 42: 159–165. doi: 10.1159/000024975
[40]
Kidd-Ljunggren K, Miyakawa Y, Kidd AH (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83: 1267–1280.
[41]
Fares MA, Holmes EC (2002) A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54: 807–814. doi: 10.1007/s00239-001-0084-z
[42]
Simmonds P, Midgley S (2005) Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 79: 15467–15476. doi: 10.1128/jvi.79.24.15467-15476.2005
[43]
Bozkaya H, Akarca US, Ayola B, Lok AS (1997) High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. J Hepatol 26: 508–516. doi: 10.1016/s0168-8278(97)80415-1
[44]
Hawkins AE, Gilson RJ, Bickerton EA, Tedder RS, Weller IV (1994) Conservation of precore and core sequences of hepatitis B virus in chronic viral carriers. J MedVirol 43: 5–12. doi: 10.1002/jmv.1890430103
[45]
Zhang D, Ma S, Zhang X, Zhao H, Ding H, et al. (2010) Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression. BMC Infect Dis 10: 271. doi: 10.1186/1471-2334-10-271
[46]
Kajiya Y, Hamasaki K, Nakata K, Miyazoe S, Takeda Y, et al. (2001) A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus. Dig Dis Sci 46: 509–515.
[47]
Wang Z, Tanaka Y, Huang Y, Kurbanov F, Chen J, et al. (2007) Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China. J Clin Microbiol 45: 1491–1496. doi: 10.1128/jcm.02157-06
[48]
Ijaz S, Ferns RB, Tedder RS (2003) A ‘first loop’ linear epitope accessible on native hepatitis B surface antigen that persists in the face of ‘second loop’ immune escape. J Gen Virol 84: 269–275. doi: 10.1099/vir.0.18667-0
[49]
Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, et al. (2010) Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang 98: 403–414. doi: 10.1111/j.1423-0410.2009.01272.x
[50]
Simon B, Kundi M, Puchhammer E (2013) Analysis of mutations in the S gene of hepatitis B virus strains in patients with chronic infection by online bioinformatics tools. J Clin Microbiol 51: 163–168. doi: 10.1128/jcm.01630-12
[51]
Hunt CM, McGill JM, Allen MI, Condreay LD (2000) Clinical relevance of hepatitis B viral mutations. Hepatology 31: 1037–1044. doi: 10.1053/he.2000.6709
[52]
Blum HE (1995) Variants of hepatitis B, C and D viruses: molecular biology and clinical significance. Digestion 56: 85–95. doi: 10.1159/000201226
[53]
Blum HE, Galun E, Liang TJ, von Weizs？cker F, Wands JR (1991) Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 65: 1836–1842.
[54]
Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, et al. (2002) Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35: 1215–1224. doi: 10.1053/jhep.2002.32710
[55]
Utsumi T, Lusida MI, Yano Y, Nugrahaputra VE, Amin M, et al. (2009) Complete genome sequence and phylogenetic relatedness of hepatitis B virus isolates in Papua, Indonesia. J ClinMicrobiol 47: 1842–1847. doi: 10.1128/jcm.02328-08
[56]
Sugauchi F, Kumada H, Acharya SA, Shrestha SM, Gamutan MT, et al. (2004) Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J GenVirol 85: 811–820. doi: 10.1099/vir.0.79811-0
[57]
Borroto-Esoda K, Miller MD, Arterburn S (2007) Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials. J Hepatol 47: 492–498. doi: 10.1016/j.jhep.2007.06.011
[58]
Choi CS, Cho EY, Park R, Kim SJ, Cho JH, et al. (2009) X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma. J MedVirol 81: 1721–1725. doi: 10.1002/jmv.21591
[59]
Kidd-Ljunggren K, Oberg M, Kidd AH (1995) The hepatitis B virus X gene: analysis of functional domain variation and gene phylogeny using multiple sequences. J GenVirol 76: 2119–2130. doi: 10.1099/0022-1317-76-9-2119
[60]
Lin X, Xu X, Huang QL, Liu YQ, Zheng DL, et al. (2005) Biological impacts of “hot-spot” mutations of hepatitis B virus X proteins are genotype B and C differentiated. World J Gastroenterol 11: 4703–4708.
[61]
Lok AS, Akarca U, Greene S (1994) Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A 91: 4077–4081. doi: 10.1073/pnas.91.9.4077
[62]
Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, et al. (2004) Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants. J Virol 78: 8524–8535. doi: 10.1128/jvi.78.16.8524-8535.2004
[63]
Ghosh S, Banerjee P, Deny P, Mondal RK, Nandi M, et al. (2013) New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India. J Viral Hepat 20: 209–218. doi: 10.1111/j.1365-2893.2012.01655.x
[64]
Warner N, Locarnini S, Kuiper M, Bartholomeusz A, Ayres A, et al. (2007) The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. AntimicrobAgents Chemother 51: 2285–2292. doi: 10.1128/aac.01499-06
[65]
Villet S, Ollivet A, Pichoud C, Barraud L, Villeneuve JP, et al. (2007) Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient. J Hepatol 46: 531–538. doi: 10.1016/j.jhep.2006.11.016
[66]
Pastor R, Habersetzer F, Fafi-Kremer S, Doffoel M, Baumert TF, et al. (2009) Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World J Gastroenterol 15: 753–755. doi: 10.3748/wjg.15.753
[67]
Langley DR, Walsh AW, Baldick CJ, Eggers BJ, Rose RE, et al. (2007) Inhibition of hepatitis B virus polymerase by entecavir. J Virol 81: 3992–4001. doi: 10.1128/jvi.02395-06
[68]
Shin YC, Ko C, Ryu WS (2011) Hydrophobic residues of terminal protein domain of hepatitis B virus polymerase contribute to distinct steps in viral genome replication. FEBS Lett 585: 3964–3968. doi: 10.1016/j.febslet.2011.11.003
[69]
Birnbaum F, Nassal M (1990) Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 64: 3319–3330.
[70]
Hannoun C, Norder H, Lindh M (2000) An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam. J Gen Virol 81: 2267–2272.
[71]
Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, et al. (2002) Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 76: 5985–5992. doi: 10.1128/jvi.76.12.5985-5992.2002
[72]
Cui C, Shi J, Hui L, Xi H, Zhuoma, et al (2002) The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid. J Gen Virol 83: 2773–2777.
[73]
Suwannakarn K, Tangkijvanich P, Theamboonlers A, Abe K, Poovorawan Y (2005) A novel recombinant of Hepatitis B virus genotypes G and C isolated from a Thai patient with hepatocellular carcinoma. J Gen Virol 86: 3027–3030. doi: 10.1099/vir.0.81241-0
[74]
Wang Z, Liu Z, Zeng G, Wen S, Qi Y, et al. (2005) A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China. J Gen Virol 86: 985–990. doi: 10.1099/vir.0.80771-0
[75]
Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J (2005) Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol 75: 513–521. doi: 10.1002/jmv.20311
[76]
Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, et al. (2001) Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol 16: 666–673. doi: 10.1046/j.1440-1746.2001.02476.x
